Stada Arzneimi Namen (STDAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 3,844,426 | 3,438,683 | 2,921,591 | 2,752,703 | 2,613,839 |
| Cost of Goods | 2,017,711 | 1,725,396 | 1,387,932 | 1,345,741 | N/A |
| Gross Profit | 1,826,715 | 1,713,287 | 1,533,659 | 1,406,962 | 2,613,839 |
| Operating Expenses | 1,289,133 | 1,344,913 | 1,102,495 | 961,226 | 0 |
| Operating Income | 538,293 | 368,770 | 432,096 | 446,477 | 2,613,839 |
| Interest Expense | 147,446 | 119,188 | 54,470 | 52,631 | 0 |
| Other Income | 2,386 | 2,286 | 3,993 | 11,088 | 0 |
| Pre-tax Income | 393,233 | 251,868 | 381,619 | 404,934 | 2,613,839 |
| Income Tax | 81,119 | 44,085 | 30,115 | 38,196 | N/A |
| Net Income Continuous | 312,114 | 207,783 | 351,504 | 366,738 | 220,955 |
| Minority Interests | 19,960 | 16,661 | 12,484 | 4,258 | N/A |
| Net Income | $292,154 | $191,123 | $339,021 | $362,481 | $96,357 |
| EPS Basic Total Ops | 4.69 | 3.07 | 5.44 | 5.82 | 1.55 |
| EPS Basic Continuous Ops | 5.01 | 3.33 | 5.64 | 5.88 | 3.55 |
| EPS Diluted Total Ops | 4.69 | 3.07 | 5.44 | 5.82 | 1.55 |
| EPS Diluted Continuous Ops | 5.01 | 3.33 | 5.65 | 5.89 | 3.55 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | 7.18 | 5.39 | 3.55 |
| EBITDA(a) | $918,391 | $648,907 | $686,337 | $622,209 | $2,613,839 |